BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 15577536)

  • 1. New CCR5 variants associated with reduced HIV coreceptor function in southeast Asia.
    Capoulade-Métay C; Ma L; Truong LX; Dudoit Y; Versmisse P; Nguyen NV; Nguyen M; Scott-Algara D; Barré-Sinoussi F; Debré P; Bismuth G; Pancino G; Theodorou I
    AIDS; 2004 Nov; 18(17):2243-52. PubMed ID: 15577536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical and HIV-1 coreceptor properties of K26R, a new CCR5 Variant in China's Sichuan population.
    Ma L; Dudoit Y; Tran T; Xing H; Chen J; Pancino G; Bismuth G; Debré P; Shao Y; Theodorou I; Capoulade-Métay C
    J Acquir Immune Defic Syndr; 2005 May; 39(1):38-43. PubMed ID: 15851912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular anatomy of CCR5 engagement by physiologic and viral chemokines and HIV-1 envelope glycoproteins: differences in primary structural requirements for RANTES, MIP-1 alpha, and vMIP-II Binding.
    Navenot JM; Wang ZX; Trent JO; Murray JL; Hu QX; DeLeeuw L; Moore PS; Chang Y; Peiper SC
    J Mol Biol; 2001 Nov; 313(5):1181-93. PubMed ID: 11700073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adaptation to promiscuous usage of CC and CXC-chemokine coreceptors in vivo correlates with HIV-1 disease progression.
    Xiao L; Rudolph DL; Owen SM; Spira TJ; Lal RB
    AIDS; 1998 Sep; 12(13):F137-43. PubMed ID: 9764773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphisms in the CCR5 coding and noncoding regions among HIV type 1-exposed, persistently seronegative female sex-workers from Thailand.
    Yang C; Li M; Limpakarnjanarat K; Young NL; Hodge T; Butera ST; McNicholl JM; Mastro TD; Lal RB
    AIDS Res Hum Retroviruses; 2003 Aug; 19(8):661-5. PubMed ID: 13678468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genotype and allele frequency of a 32-base pair deletion mutation in the CCR5 gene in various ethnic groups: absence of mutation among Asians and Pacific Islanders.
    Lu Y; Nerurkar VR; Dashwood WM; Woodward CL; Ablan S; Shikuma CM; Grandinetti A; Chang H; Nguyen HT; Wu Z; Yamamura Y; Boto WO; Merriwether A; Kurata T; Detels R; Yanagihara R
    Int J Infect Dis; 1999; 3(4):186-91. PubMed ID: 10575146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global survey of genetic variation in CCR5, RANTES, and MIP-1alpha: impact on the epidemiology of the HIV-1 pandemic.
    Gonzalez E; Dhanda R; Bamshad M; Mummidi S; Geevarghese R; Catano G; Anderson SA; Walter EA; Stephan KT; Hammer MF; Mangano A; Sen L; Clark RA; Ahuja SS; Dolan MJ; Ahuja SK
    Proc Natl Acad Sci U S A; 2001 Apr; 98(9):5199-204. PubMed ID: 11320252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variants of CCR5, which are permissive for HIV-1 infection, show distinct functional responses to CCL3, CCL4 and CCL5.
    Dong HF; Wigmore K; Carrington MN; Dean M; Turpin JA; Howard OM
    Genes Immun; 2005 Oct; 6(7):609-19. PubMed ID: 16015368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV type 1 coreceptor tropism, CCR5 genotype, and integrase inhibitor resistance profiles in Vietnam: implications for the introduction of new antiretroviral regimens.
    Luu QP; Dean J; Do TT; Carr MJ; Dunford L; Coughlan S; Connell J; Nguyen HT; Hall WW; Nguyen Thi LA
    AIDS Res Hum Retroviruses; 2012 Oct; 28(10):1344-8. PubMed ID: 22264071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterozygosity for a defective gene for CC chemokine receptor 5 is not the sole determinant for the immunologic and virologic phenotype of HIV-infected long-term nonprogressors.
    Cohen OJ; Vaccarezza M; Lam GK; Baird BF; Wildt K; Murphy PM; Zimmerman PA; Nutman TB; Fox CH; Hoover S; Adelsberger J; Baseler M; Arthos J; Davey RT; Dewar RL; Metcalf J; Schwartzentruber DJ; Orenstein JM; Buchbinder S; Saah AJ; Detels R; Phair J; Rinaldo C; Margolick JB; Pantaleo G; Fauci AS
    J Clin Invest; 1997 Sep; 100(6):1581-9. PubMed ID: 9294127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CCR5 genotype and plasma beta-chemokine concentration of Brazilian HIV-infected individuals.
    Mikawa AY; Tagliavini SA; Costa PI
    Braz J Med Biol Res; 2002 Nov; 35(11):1333-7. PubMed ID: 12426633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterozygous defect in HIV-1 coreceptor CCR5 and chemokine production.
    Yang JY; Togni M; Widmer U
    Cytokine; 1999 Jan; 11(1):1-7. PubMed ID: 10080873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular characterization of the CCR 5 gene in seronegative individuals exposed to human immunodeficiency virus (HIV).
    Rugeles MT; Solano F; Díaz FJ; Bedoya VI; Patiño PJ
    J Clin Virol; 2002 Jan; 23(3):161-9. PubMed ID: 11595595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple nonfunctional alleles of CCR5 are frequent in various human populations.
    Blanpain C; Lee B; Tackoen M; Puffer B; Boom A; Libert F; Sharron M; Wittamer V; Vassart G; Doms RW; Parmentier M
    Blood; 2000 Sep; 96(5):1638-45. PubMed ID: 10961858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Single nucleotide polymorphisms of HIV coreceptor CCR5 gene in Chinese Yi ethnic group and its association with HIV infection].
    Ma LY; Hong KX; Lu XZ; Qin GM; Chen JP; Chen KL; Ruan YH; Xing H; Zhu JH; Shao YM
    Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(45):3181-5. PubMed ID: 16405836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced CD4 T cell activation and in vitro susceptibility to HIV-1 infection in exposed uninfected Central Africans.
    Bégaud E; Chartier L; Marechal V; Ipero J; Léal J; Versmisse P; Breton G; Fontanet A; Capoulade-Metay C; Fleury H; Barré-Sinoussi F; Scott-Algara D; Pancino G
    Retrovirology; 2006 Jun; 3():35. PubMed ID: 16792805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of CCR5-59029 A/G and CCL3L1 copy number polymorphism with HIV type 1 transmission/progression among HIV type 1-seropositive and repeatedly sexually exposed HIV type 1-seronegative North Indians.
    Rathore A; Chatterjee A; Sivarama P; Yamamoto N; Singhal PK; Dhole TN
    AIDS Res Hum Retroviruses; 2009 Nov; 25(11):1149-56. PubMed ID: 19886839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of genetic polymorphisms in CCR5, CCR2, stromal cell-derived factor-1, RANTES, and dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin in seronegative individuals repeatedly exposed to HIV-1.
    Liu H; Hwangbo Y; Holte S; Lee J; Wang C; Kaupp N; Zhu H; Celum C; Corey L; McElrath MJ; Zhu T
    J Infect Dis; 2004 Sep; 190(6):1055-8. PubMed ID: 15319853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of both the V2 and V3 regions of the CCR5-tropic human immunodeficiency virus type 1 envelope in reduced sensitivity to macrophage inflammatory protein 1alpha.
    Maeda Y; Foda M; Matsushita S; Harada S
    J Virol; 2000 Feb; 74(4):1787-93. PubMed ID: 10644351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inherited resistance to HIV-1 conferred by an inactivating mutation in CC chemokine receptor 5: studies in populations with contrasting clinical phenotypes, defined racial background, and quantified risk.
    Zimmerman PA; Buckler-White A; Alkhatib G; Spalding T; Kubofcik J; Combadiere C; Weissman D; Cohen O; Rubbert A; Lam G; Vaccarezza M; Kennedy PE; Kumaraswami V; Giorgi JV; Detels R; Hunter J; Chopek M; Berger EA; Fauci AS; Nutman TB; Murphy PM
    Mol Med; 1997 Jan; 3(1):23-36. PubMed ID: 9132277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.